<code id='176BB0C3C6'></code><style id='176BB0C3C6'></style>
    • <acronym id='176BB0C3C6'></acronym>
      <center id='176BB0C3C6'><center id='176BB0C3C6'><tfoot id='176BB0C3C6'></tfoot></center><abbr id='176BB0C3C6'><dir id='176BB0C3C6'><tfoot id='176BB0C3C6'></tfoot><noframes id='176BB0C3C6'>

    • <optgroup id='176BB0C3C6'><strike id='176BB0C3C6'><sup id='176BB0C3C6'></sup></strike><code id='176BB0C3C6'></code></optgroup>
        1. <b id='176BB0C3C6'><label id='176BB0C3C6'><select id='176BB0C3C6'><dt id='176BB0C3C6'><span id='176BB0C3C6'></span></dt></select></label></b><u id='176BB0C3C6'></u>
          <i id='176BB0C3C6'><strike id='176BB0C3C6'><tt id='176BB0C3C6'><pre id='176BB0C3C6'></pre></tt></strike></i>

          Home / explore / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:48
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In